Suppr超能文献

动态伤口微生物组。

The dynamic wound microbiome.

机构信息

Department of Biosystems Engineering, University of Arizona, Tucson, AZ, USA.

BIO5 Institute, University of Arizona, Tucson, AZ, USA.

出版信息

BMC Med. 2020 Nov 24;18(1):358. doi: 10.1186/s12916-020-01820-6.

Abstract

BACKGROUND

Diabetic foot ulcers (DFUs) account for the majority of all limb amputations and hospitalizations due to diabetes complications. With 30 million cases of diabetes in the USA and 500,000 new diagnoses each year, DFUs are a growing health problem. Diabetes patients with limb amputations have high postoperative mortality, a high rate of secondary amputation, prolonged inpatient hospital stays, and a high incidence of re-hospitalization. DFU-associated amputations constitute a significant burden on healthcare resources that cost more than 10 billion dollars per year. Currently, there is no way to identify wounds that will heal versus those that will become severely infected and require amputation.

MAIN BODY

Accurate identification of causative pathogens in diabetic foot ulcers is a critical component of effective treatment. Compared to traditional culture-based methods, advanced sequencing technologies provide more comprehensive and unbiased profiling on wound microbiome with a higher taxonomic resolution, as well as functional annotation such as virulence and antibiotic resistance. In this review, we summarize the latest developments in defining the microbiology of diabetic foot ulcers that have been unveiled by sequencing technologies and discuss both the future promises and current limitations of these approaches. In particular, we highlight the temporal patterns and system dynamics in the diabetic foot microbiome monitored and measured during wound progression and medical intervention, and explore the feasibility of molecular diagnostics in clinics.

CONCLUSION

Molecular tests conducted during weekly office visits to clean and examine DFUs would allow clinicians to offer personalized treatment and antibiotic therapy. Personalized wound management could reduce healthcare costs, improve quality of life for patients, and recoup lost productivity that is important not only to the patient, but also to healthcare payers and providers. These efforts could also improve antibiotic stewardship and control the rise of "superbugs" vital to global health.

摘要

背景

糖尿病足溃疡(DFU)占所有因糖尿病并发症导致的截肢和住院的主要原因。美国有 3000 万例糖尿病患者,每年新增 50 万例,DFU 是一个日益严重的健康问题。糖尿病患者截肢后术后死亡率高,二次截肢率高,住院时间延长,再住院率高。DFU 相关截肢给医疗资源带来了巨大负担,每年花费超过 100 亿美元。目前,尚无方法可以识别哪些伤口会愈合,哪些伤口会严重感染并需要截肢。

主要内容

准确识别糖尿病足溃疡的致病病原体是有效治疗的关键组成部分。与传统的基于培养的方法相比,先进的测序技术提供了更全面、更公正的伤口微生物组分析,具有更高的分类分辨率,以及功能注释,如毒力和抗生素耐药性。在这篇综述中,我们总结了测序技术揭示的糖尿病足溃疡微生物学的最新进展,并讨论了这些方法的未来前景和当前限制。特别是,我们强调了在伤口进展和医疗干预过程中监测和测量的糖尿病足微生物组的时间模式和系统动态,并探讨了分子诊断在临床中的可行性。

结论

在每周的办公室就诊中进行分子检测,以清洁和检查 DFU,可以让临床医生提供个性化的治疗和抗生素治疗。个性化的伤口管理可以降低医疗成本,提高患者的生活质量,并弥补因疾病导致的生产力损失,这不仅对患者很重要,对医疗保健支付方和提供者也很重要。这些努力还可以改善抗生素管理,控制对全球健康至关重要的“超级细菌”的出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5d/7685579/c314a9b215cd/12916_2020_1820_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验